$CLS stock has now risen 12% today, according to our price data from Polygon. There has been approximately $1,021,052,012 of trading volume.
It has been the 71st most-searched ticker on Quiver Quantitative over the last day, out of 10,293 total tickers searched.
Here is what we see in our data on $CLS (you can track the company live on Quiver's $CLS stock page):
$CLS Insider Trading Activity
$CLS insiders have traded $CLS stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CLS stock by insiders over the last 6 months:
- LAURETTE T KOELLNER has made 4 purchases buying 6,000 shares for an estimated $2,050,025 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLS Hedge Fund Activity
We have seen 390 institutional investors add shares of $CLS stock to their portfolio, and 379 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 2,756,491 shares (+601.9%) to their portfolio in Q3 2025, for an estimated $679,144,252
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,596,318 shares (+471.5%) to their portfolio in Q3 2025, for an estimated $639,680,828
- VIKING GLOBAL INVESTORS LP added 1,722,780 shares (+inf%) to their portfolio in Q3 2025, for an estimated $424,458,536
- WHALE ROCK CAPITAL MANAGEMENT LLC removed 1,645,780 shares (-35.5%) from their portfolio in Q3 2025, for an estimated $405,487,276
- ALKEON CAPITAL MANAGEMENT LLC removed 1,230,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $192,015,300
- JERICHO CAPITAL ASSET MANAGEMENT L.P. removed 962,500 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $237,140,750
- INVESCO LTD. removed 855,903 shares (-65.9%) from their portfolio in Q3 2025, for an estimated $210,877,381
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLS Congressional Stock Trading
Members of Congress have traded $CLS stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CLS stock by members of Congress over the last 6 months:
- REPRESENTATIVE CLEO FIELDS has traded it 2 times. They made 2 purchases worth up to $100,000 on 11/03, 10/31 and 0 sales.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CLS Analyst Ratings
Wall Street analysts have issued reports on $CLS in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 11/14/2025
- Citigroup issued a "Buy" rating on 11/10/2025
- Stifel issued a "Buy" rating on 10/29/2025
- Goldman Sachs issued a "Buy" rating on 10/29/2025
- CIBC issued a "Outperformer" rating on 10/29/2025
- RBC Capital issued a "Outperform" rating on 10/22/2025
- JP Morgan issued a "Overweight" rating on 09/08/2025
To track analyst ratings and price targets for $CLS, check out Quiver Quantitative's $CLS forecast page.
$CLS Price Targets
Multiple analysts have issued price targets for $CLS recently. We have seen 12 analysts offer price targets for $CLS in the last 6 months, with a median target of $359.5.
Here are some recent targets:
- George Wang from Barclays set a target price of $359.0 on 11/14/2025
- Atif Malik from Citigroup set a target price of $375.0 on 11/10/2025
- Ruben Roy from Stifel set a target price of $385.0 on 10/29/2025
- David Vogt from UBS set a target price of $350.0 on 10/29/2025
- Paul Treiber from RBC Capital set a target price of $400.0 on 10/29/2025
- Samik Chatterjee from JP Morgan set a target price of $360.0 on 10/29/2025
- Todd Coupland from CIBC set a target price of $400.0 on 10/29/2025
You can track data on $CLS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.